Sequential treatment with targeted and immune checkpoint inhibitor therapies in patients with BRAF positive metastatic melanoma: Real-world data.

被引：0
|
作者：
Cybulska-Stopa, Bozena
Czarnecka, Anna Malgorzata
Ostaszewski, Krzysztof
Piejko, Karolina
Zietek, Marcin
Dziura, Robert
Rutkowska, Ewa
Galus, Lukasz
Ziolkowska, Barbara
Kempa-Kaminska, Natasza
Seredynska, Joanna
Kamycka, Agnieszka
Bal, Wieslaw
Surus-Hyla, Anna
Switaj, Tomasz
Rogala, Pawel
Kaminska-Winciorek, Grazyna
Suwinski, Rafal
Mackiewicz, Jacek
Rutkowski, Piotr
机构：
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Clin Oncol, Cracow Branch, Krakow, Poland
[2] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
[3] Wroclaw Med Univ, Dept Oncol, Wroclaw, Poland
[4] Wroclaw Comprehens Canc Ctr, Dept Surg Oncol, Wroclaw, Poland
[5] Holy Cross Canc Ctr, Dept Clin Oncol, Kielce, Poland
[6] Univ Med Sci, Dept Med & Expt Oncol, Heliodor Swiecicki Clin Hosp, Poznan, Poland
[7] Maria Sklodowska Curie Natl Res Inst Oncol, Clin Radiotherapy & Chemotherapy 2, Gliwice Branch, Gliwice, Poland
[8] Wroclaw Comprehens Canc Ctr, Dept Clin Oncol, Wroclaw, Poland
[9] Podkarpacki Centrum Onkol Rzeszowie, Rzeszow, Poland
[10] Gliwice Oncol Inst, Gliwice, Poland
[11] Minist Interior & Adm Hosp, Clin Dept Oncol & Immuno Oncol, Warmian Masurian Canc Ctr, Olsztyn, Poland
[12] Maria Sklodowska Curie Natl Res Inst Oncol, Gliwice Branch, Dept Bone Marrow Transplantat & Onco Hematol, Skin Canc & Melanoma Team, Gliwice, Poland
[13] Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, Poznan, Poland
[14] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21539
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
    Graetz, Victoria
    Zillikens, Detlef
    Busch, Hauke
    Langan, Ewan A.
    Terheyden, Patrick
    FRONTIERS IN MEDICINE, 2019, 6
  • [2] Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive
    Ghate, Sameer
    Ionescu-Ittu, Raluca
    Burne, Rebecca
    Ndife, Briana
    Laliberte, Francois
    Nakasato, Antonio
    Duh, Mei Sheng
    MELANOMA RESEARCH, 2019, 29 (03) : 301 - 310
  • [3] Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in BRAF Mutation-Positive NSCLC
    Gibson, Amanda J. W.
    Pabani, Aliyah
    Dean, Michelle L.
    Martos, Guillermo
    Cheung, Winson Y.
    Navani, Vishal
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (03):
  • [4] Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
    Bol, Kalijn Fredrike
    Ellebaek, Eva
    Hoejberg, Lise
    Bagger, Mette Marie
    Larsen, Mathilde Skaarup
    Klausen, Tobias Wirenfeldt
    Kohler, Ulrich Heide
    Schmidt, Henrik
    Bastholt, Lars
    Kiilgaard, Jens Folke
    Donia, Marco
    Svane, Inge Marie
    CANCERS, 2019, 11 (10)
  • [5] Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists
    Kakavand, Hojabr
    Wilmott, James S.
    Long, Georgina V.
    Scolyer, Richard A.
    PATHOLOGY, 2016, 48 (02) : 194 - 202
  • [6] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
    Bol, K. F.
    Ellebaek, E.
    Donia, M.
    Schmidt, H.
    Bastholt, L.
    Kiilgaard, J. F.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
  • [7] Utilization of real-world data to assess the effectiveness of immune checkpoint inhibitors (ICIs) in elderly patients with metastatic melanoma
    Ernst, D. S.
    McConkey, H.
    Liu, L.
    Butler, M. O.
    Petrella, T.
    Baetz, T.
    Koneru, R.
    Song, X.
    Cheng, T.
    Smylie, M. G.
    Rajagopal, S.
    Mihalcioiu, C.
    Gwadry-Sridhar, F.
    ANNALS OF ONCOLOGY, 2019, 30 : 553 - 553
  • [8] New Developments in the Treatment of Metastatic Melanoma: Immune Checkpoint Inhibitors and Targeted Therapies
    Azijli, Kaamar
    Stelloo, Ellen
    Peters, Godefridus J.
    Van den Eertwegh, Alfons J. M.
    ANTICANCER RESEARCH, 2014, 34 (04) : 1493 - 1505
  • [9] Sequential systemic treatment in patients with hepatocellular carcinoma: real-world data in the era of immune checkpoint inhibition
    Pauly, Jana
    Wehling, Cyrill
    Springfeld, Christoph
    Tomczak, Aurelie
    Chang, De-Hua
    Liermann, Jakob
    Kratochwil, Clemens
    Mehrabi, Arianeb
    Brockschmidt, Antje
    Longerich, Thomas
    Rauber, Conrad
    Pfeiffenberger, Jan
    Michl, Patrick
    Dill, Michael
    JOURNAL OF HEPATOLOGY, 2023, 78 : S594 - S594
  • [10] Outcome of Elective Checkpoint Inhibitor Discontinuation in Patients with Metastatic Melanoma Who Achieved a Complete Remission: Real-World Data
    Perez, Leanne
    Samlowski, Wolfram
    Lopez-Flores, Ruby
    BIOMEDICINES, 2022, 10 (05)
12345